Endoplasmic Reticulum Stress Increases Multidrug-resistance Protein 2 Expression and Mitigates Acute Liver Injury

Wen-Ge Huang1, Jun Wang1, Yu-Juan Liu1

  • 1Department of Infectious Diseases, the Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, Guizhou, China.

Abstract

Insights

Endoplasmic reticulum (ER) stress increases multidrug-resistance protein (MRP) 2 expression via nuclear factor kappa B (NF-κB) activation. This MRP2 upregulation protects against ER stress and acute liver injury.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cellular Stress Response

Background:

  • Multidrug-resistance protein (MRP) 2 is a hepatocyte transporter regulated by nuclear factor kappa B (NF-κB).
  • Endoplasmic reticulum (ER) stress is linked to liver injury and NF-κB activation.

Purpose of the Study:

  • Investigate the effect of ER stress on MRP2 expression.
  • Determine MRP2's role in acute liver injury.

Main Methods:

  • Utilized carbon tetrachloride (CCl4) and thapsigargin (TG) mouse models for acute liver injury and ER stress.
  • Analyzed ER stress, MRP2 expression, and NF-κB activation in vivo and in vitro (LO2 cells).
  • Assessed the impact of ER stress inhibitor (PBA) and NF-κB inhibitor (PDTC) on these markers.

Main Results:

  • CCl4 and TG treatments significantly induced ER stress, MRP2 expression, and NF-κB activation.
  • ER stress inhibition (PBA) reduced ER stress and MRP2 levels.
  • NF-κB inhibition (PDTC) decreased NF-κB activation and MRP2 expression.
  • Downregulation of MRP2 exacerbated CCl4-induced ER stress, apoptosis, and liver injury.

Conclusions:

  • ER stress upregulates intrahepatic MRP2 protein expression through NF-κB activation.
  • Increased MRP2 expression confers protection against ER stress and acute liver injury.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.1K
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
6.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
172
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
137
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.9K